Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Ugeskr Laeger ; 185(27)2023 07 03.
Article in Danish | MEDLINE | ID: mdl-37539810

ABSTRACT

The majority of Danish women are working, and many are standing/walking or lifting heavy objects at work. It is important for employers and employees to assess ergonomic risk factors in the work environment during pregnancy to avoid potential negative effects on the pregnancy. Studies show that walking/standing > 3-4 h/d may increase the risk of preterm delivery. It is difficult to set specific limits due to heterogenous exposures regarding heavy lifting. Though, results suggest that women should avoid lifting >10 kg repeatedly at work during pregnancy to avoid adverse effects of the pregnancy.


Subject(s)
Occupational Exposure , Premature Birth , Infant, Newborn , Pregnancy , Female , Humans , Pregnant Women , Working Conditions , Premature Birth/etiology , Risk Factors , Ergonomics , Occupational Exposure/adverse effects
2.
Diabetes Metab Res Rev ; 35(3): e3110, 2019 03.
Article in English | MEDLINE | ID: mdl-30517978

ABSTRACT

BACKGROUND: Statins are widely used to lower cholesterol concentrations in both primary and secondary prevention of cardiovascular disease. The treatment increases the risk of muscle pain (myalgia) and of type 2 diabetes. However, the underlying mechanisms remain disputed. METHODS: We investigated whether statin induced myalgia is coupled to impaired glucose homeostasis using oral glucose tolerance test (OGTT), intravenous glucose tolerance test (IVGTT), and the hyperinsulinemic euglycemic clamp. We performed a cross-sectional study of statin users without CVD (primary prevention) stratified into a statin myalgic (M; n = 25) and a non-myalgic (NM; n = 39) group as well as a control group (C; n = 20) consisting of non-statin users. RESULTS: A reduction in the insulin secretion rate during the OGTT was observed in the myalgic group compared with the non-myalgic group (AUC ISROGTT , C: 1032 (683 - 1500); M: 922 (678 - 1091); NM: 1089 (933 - 1391) pmol·L-1 ·min (median with 25%-75% percentiles), but no other measurements indicated impaired ß-cell function. We found no other differences between the three groups for other measurements in the OGTT, IVGTT, and euglycemic clamp. Muscle protein content of GLUT4 and hexokinase II was similar between the three groups. CONCLUSIONS: We conclude that statin users in primary prevention experiencing myalgia do not have impaired glucose homeostasis compared with other statin users or non-users. We consider this an important aspect in the dialogue between physician and patient regarding statin treatment and adverse effects.


Subject(s)
Cardiovascular Diseases/prevention & control , Glucose Intolerance/drug therapy , Homeostasis , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Insulin Resistance , Cross-Sectional Studies , Female , Follow-Up Studies , Glucose Tolerance Test , Humans , Male , Middle Aged , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...